The Federal Commerce Fee requested a federal decide to carry “pharma bro” Martin Shkreli in contempt for failing to supply the company with data wanted to find out whether or not he’s violating an order that completely banned him from working within the pharmaceutical trade.
In a movement filed federal courtroom in New York, the FTC and 7 state regulators argued that Shkreli has did not adjust to their requests to supply paperwork and sit for an interview as a part of their investigation into whether or not he violated the ban by forming and working his new firm, which known as Druglike Inc.
Proceed to STAT+ to learn the total story…
